![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
(51) | INT.CL. | A61K 9/72 | (2006.01) |
A61K 9/00 | (2006.01) | ||
A61K 31/439 | (2006.01) | ||
A61K 31/46 | (2006.01) | ||
A61K 31/575 | (2006.01) | ||
A61K 31/58 | (2006.01) | ||
A61K 45/00 | (2006.01) | ||
A61K 45/06 | (2006.01) | ||
A61K 47/26 | (2006.01) | ||
A61M 11/00 | (2006.01) | ||
A61M 15/00 | (2006.01) | ||
A61P 5/44 | (2006.01) | ||
A61P 5/46 | (2006.01) | ||
A61P 11/00 | (2006.01) | ||
A61P 11/06 | (2006.01) | ||
A61P 29/00 | (2006.01) | ||
A61P 37/08 | (2006.01) | ||
A61P 43/00 | (2006.01) | ||
C07J 31/00 | (2006.01) |
(11) | Patento numeris | 1471919 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 03706683.4 |
Europos patento paraiškos padavimo data | 2003-02-04 | |
(97) | Europos patento paraiškos paskelbimo data | 2004-11-03 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2005-08-10 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/GB2003/000491 |
Data | 2003-02-04 |
(87) | Numeris | WO 2003/066063 |
Data | 2003-08-14 |
(30) | Numeris | Data | Šalis |
0202635 | 2002-02-05 | GB |
(72) |
BIGGADIKE, Keith GlaxoSmithKline, GB
|
(73) |
GLAXO GROUP LIMITED,
Glaxo Wellcome House, Berkeley Avenue, Greenford, Middlesex UB6 0NN,
GB
|
(54) | PHARMACEUTICAL COMPOSITIONS COMPRISING 17ALPHA-FURANYLESTERS OF 17BETA-CARBOTHIOATE ANDROSTANES WITH A MUSCARINIC RECEPTOR ANTAGONIST |
PHARMACEUTICAL COMPOSITIONS COMPRISING 17ALPHA-FURANYLESTERS OF 17BETA-CARBOTHIOATE ANDROSTANES WITH A MUSCARINIC RECEPTOR ANTAGONIST |